Ameriprise Financial Inc Ascendis Pharma A/S Transaction History
Ameriprise Financial Inc
- $388 Billion
- Q2 2025
A detailed history of Ameriprise Financial Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ameriprise Financial Inc holds 588,069 shares of ASND stock, worth $118 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
588,069
Previous 679,943
13.51%
Holding current value
$118 Million
Previous $106 Million
4.22%
% of portfolio
0.03%
Previous 0.03%
Shares
26 transactions
Others Institutions Holding ASND
# of Institutions
276Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.07 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.1 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$1 Billion15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$890 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$855 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.2B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...